Clinical trial
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to…
NCT00499902 · ARCA Biopharma, Inc., Industry · Terminated
Key facts
| NCT number | NCT00499902 |
|---|---|
| Title | Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke |
| Official title | Phase 2, Multicenter, Open-Label, Two-Stage Study to Evaluate the Safety and Efficacy of Intra-Arterial Catheter-Directed Alfimeprase for Restoration of Neurologic Function and Rapid Opening of Arteries in Stroke (CARNEROS-1) |
| Lead sponsor | ARCA Biopharma, Inc., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Ischemic Stroke |
| Intervention type | Drug |
| Interventions | alfimeprase |
| Enrollment | 7 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 12, 2007 |
| Last update posted | Apr 24, 2008 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: